Delivery Order SPE2DB20D3303-SPE2DB24FA1RL

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,130.03 Firm Fixed Price Delivery Order contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The $16,476.49 firm fixed-price delivery order has a completion date of July 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $78,517.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The award is a Delivery Order contract with a Firm Fixed Price pricing type, with a period of performance through May 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $14,899.49 firm fixed price delivery order contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop...
This federal contract award is a Delivery Order with a Firm Fixed Price pricing type, valued at $16,078.45, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, with an ultimate completion date of June 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,246.55 Firm Fixed Price Delivery Order contract is for the provision of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a specialty pharmaceutical product, with a ceiling value of $6,158.65 and a period of performance through March 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $85,863.64 firm fixed-price delivery order is for the supply of GILENYA 0.5 MG capsules, a medication used to treat multiple sclerosis. The contract has an ultimate completion date of January 31, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,556,764,359 units of the medication GILENYA 0.5 MG CAPSULE. The $18,358.08 firm fixed-price delivery order has an ultimate completion date of April 4, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $90,558.22, is for the provision of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of October 31, 2023 and is a Firm Fixed Price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA1RL
    Delivery Order

This federal contract award, valued at $20,258.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GILENYA 0.5 MG CAPSULE 30S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 2, 2024.

Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, to provide a wide range of pharmaceutical and medical supplies to support various government healthcare programs and facilities, including military treatment centers. This specific award does not have a set-aside designation.

Generated 10/31/24, 10:43 AM